Terapia Génica en Enfermedad de Parkinson
PARKBA SAL
Karolinska Institute
Estocolmo, SueciaPublicaciones en colaboración con investigadores/as de Karolinska Institute (2)
2018
-
Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Role of CB1 and CB2 receptors and relevance for Alzheimer's disease and levodopa-induced dyskinesia
Brain, Behavior, and Immunity, Vol. 67, pp. 139-151
2009
-
Interactions between calmodulin, adenosine A2A, and dopamine D2 receptors
Journal of Biological Chemistry, Vol. 284, Núm. 41, pp. 28058-28068